Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

November 12, 2018 - 5:02 p.m.
Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27Printer Friendly Version 
November 09, 2018 - 8:01 a.m.
Gilead Announces Positive Phase 2 Results for GS-9674 in Primary Sclerosing Cholangitis (PSC) at The Liver Meeting® 2018Printer Friendly Version 

Upcoming Events

Tuesday, November 27, 2018 9:30 a.m. ET
Gilead Sciences at the Evercore ISI HealthCONx Conference

Most Viewed Links

Updated 11/08/18
1.SEC Filings
2.Earnings
3.Annual Reports
4.Fundamentals - Snapshot
5.Stock Information
* Data collected 10/31/18 - 11/07/18

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$69.20
 Stock is Down 0.58 (0.83%)
Data as of 11/16/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Third Quarter 2018 Gilead Sciences Earnings Conference Call

October 25, 2018 4:30 p.m. ET
Play
Gilead Sciences at the Morgan Stanley 16th Annual Global Healthcare Conference

September 12, 2018 11:05 a.m. ET
Play
Second Quarter 2018 Gilead Sciences Earnings Conference Call

July 25, 2018 2:00 p.m. PT
Play
Gilead Sciences at the Goldman Sachs 39th Annual Global Healthcare Conference

June 13, 2018 8:40 a.m. PT
Play